Medications for Opioid Use Disorder in Primary Care

POSTPONED

Description:

This webinar will review the Food and Drug Administration (FDA)-approved medications for the treatment of opioid use disorder (OUD) and address some of the barriers to their integration into primary care. Participants will learn ways to discuss medication options with patients seeking treatment for OUD and will be introduced to the latest, evidence-based screening tools and integration resources.

Earn 1 Behavioral Health continuing education credit (CEUs) for attending this webinar.

Objectives:

Participants in this webinar will be able to:

  • Identify the available tools for OUD screening that may be integrated into their primary care practices. 
  • Define treatment options for MOUD with their patients. 
  • Demonstrate and understand the importance of using non-stigmatizing language in their practices.  
  • Identify strategies to create plans to coordinate behavioral health concerns/needs of patients with MOUD. 

Presenter:

Todd "Akiva" Mandell, MD

Todd “Akiva” Mandell, MD, Senior Associate, Addiction Medicine, Bizzell US, is a board-certified psychiatrist of more than 30 years with added qualifications in addiction psychiatry. His work experience has included direct clinical treatment at the inpatient, partial hospitalization, outpatient, and residential levels of care as well as in administration. Dr. Mandell served for eight years as the medical director for the Vermont State Office of Drug and Alcohol programs, where he was a key participant in the creation of the Vermont Hub and Spoke Model for delivery of medication for opioid use disorder. Prior to joining Bizzell US, he served for five years as the chief medical officer for Community Substance Abuse Centers in New England. He currently supports training and technical assistance activities for Bizzell US as a subject-matter expert.